326 related articles for article (PubMed ID: 38162229)
21. Liver microphysiological platforms for drug metabolism applications.
Kulsharova G; Kurmangaliyeva A
Cell Prolif; 2021 Sep; 54(9):e13099. PubMed ID: 34291515
[TBL] [Abstract][Full Text] [Related]
22. Microphysiological systems for human aging research.
Park S; Laskow TC; Chen J; Guha P; Dawn B; Kim DH
Aging Cell; 2024 Mar; 23(3):e14070. PubMed ID: 38180277
[TBL] [Abstract][Full Text] [Related]
23. Integrating Biosensors in Organs-on-Chip Devices: A Perspective on Current Strategies to Monitor Microphysiological Systems.
Ferrari E; Palma C; Vesentini S; Occhetta P; Rasponi M
Biosensors (Basel); 2020 Aug; 10(9):. PubMed ID: 32872228
[TBL] [Abstract][Full Text] [Related]
24. The future of phenotypic drug discovery.
Berg EL
Cell Chem Biol; 2021 Mar; 28(3):424-430. PubMed ID: 33529582
[TBL] [Abstract][Full Text] [Related]
25. From organ-on-chip to body-on-chip: The next generation of microfluidics platforms for in vitro drug efficacy and toxicity testing.
Lacombe J; Soldevila M; Zenhausern F
Prog Mol Biol Transl Sci; 2022; 187(1):41-91. PubMed ID: 35094781
[TBL] [Abstract][Full Text] [Related]
26. Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.
Ewart L; Dehne EM; Fabre K; Gibbs S; Hickman J; Hornberg E; Ingelman-Sundberg M; Jang KJ; Jones DR; Lauschke VM; Marx U; Mettetal JT; Pointon A; Williams D; Zimmermann WH; Newham P
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():65-82. PubMed ID: 29029591
[TBL] [Abstract][Full Text] [Related]
27. Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies.
Edington CD; Chen WLK; Geishecker E; Kassis T; Soenksen LR; Bhushan BM; Freake D; Kirschner J; Maass C; Tsamandouras N; Valdez J; Cook CD; Parent T; Snyder S; Yu J; Suter E; Shockley M; Velazquez J; Velazquez JJ; Stockdale L; Papps JP; Lee I; Vann N; Gamboa M; LaBarge ME; Zhong Z; Wang X; Boyer LA; Lauffenburger DA; Carrier RL; Communal C; Tannenbaum SR; Stokes CL; Hughes DJ; Rohatgi G; Trumper DL; Cirit M; Griffith LG
Sci Rep; 2018 Mar; 8(1):4530. PubMed ID: 29540740
[TBL] [Abstract][Full Text] [Related]
28. Translational Roadmap for the Organs-on-a-Chip Industry toward Broad Adoption.
Allwardt V; Ainscough AJ; Viswanathan P; Sherrod SD; McLean JA; Haddrick M; Pensabene V
Bioengineering (Basel); 2020 Sep; 7(3):. PubMed ID: 32947816
[TBL] [Abstract][Full Text] [Related]
29. Organs-on-a-Chip.
Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
[TBL] [Abstract][Full Text] [Related]
30. Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review.
Sun AM; Hoffman T; Luu BQ; Ashammakhi N; Li S
Biodes Manuf; 2021; 4(4):757-775. PubMed ID: 34178414
[TBL] [Abstract][Full Text] [Related]
31. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
[TBL] [Abstract][Full Text] [Related]
32. Application of microphysiological systems for nonclinical evaluation of cell therapies.
Candarlioglu P; Delsing L; Gauthier L; Lewis L; Papadopoulos G; Freag M; Chan TS; Homan K; Fellows MD; Pointon A; Kojala K
ALTEX; 2024 May; ():. PubMed ID: 38746991
[TBL] [Abstract][Full Text] [Related]
33. National reflection on organs-on-chip for drug development: New regulatory challenges.
Teixeira SG; Houeto P; Gattacceca F; Petitcollot N; Debruyne D; Guerbet M; Guillemain J; Fabre I; Louin G; Salomon V
Toxicol Lett; 2023 Oct; 388():1-12. PubMed ID: 37776962
[TBL] [Abstract][Full Text] [Related]
34. Organs-on-a-chip: a new tool for drug discovery.
Polini A; Prodanov L; Bhise NS; Manoharan V; Dokmeci MR; Khademhosseini A
Expert Opin Drug Discov; 2014 Apr; 9(4):335-52. PubMed ID: 24620821
[TBL] [Abstract][Full Text] [Related]
35. [Toward Regulatory Acceptance of MPS-Cardiac Safety Assessment as an Example].
Yamazaki D
Yakugaku Zasshi; 2023; 143(1):55-63. PubMed ID: 36596540
[TBL] [Abstract][Full Text] [Related]
36. Maximizing the impact of microphysiological systems with in vitro-in vivo translation.
Cirit M; Stokes CL
Lab Chip; 2018 Jun; 18(13):1831-1837. PubMed ID: 29863727
[TBL] [Abstract][Full Text] [Related]
37. Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility.
Pamies D; Ekert J; Zurich MG; Frey O; Werner S; Piergiovanni M; Freedman BS; Keong Teo AK; Erfurth H; Reyes DR; Loskill P; Candarlioglu P; Suter-Dick L; Wang S; Hartung T; Coecke S; Stacey GN; Wagegg BA; Dehne EM; Pistollato F; Leist M
Stem Cell Reports; 2024 May; 19(5):604-617. PubMed ID: 38670111
[TBL] [Abstract][Full Text] [Related]
38. Integrated biosensors for monitoring microphysiological systems.
Mou L; Mandal K; Mecwan MM; Hernandez AL; Maity S; Sharma S; Herculano RD; Kawakita S; Jucaud V; Dokmeci MR; Khademhosseini A
Lab Chip; 2022 Oct; 22(20):3801-3816. PubMed ID: 36074812
[TBL] [Abstract][Full Text] [Related]
39. In Vitro Tumor Models on Chip and Integrated Microphysiological Analysis Platform (MAP) for Life Sciences and High-Throughput Drug Screening.
Ngo H; Amartumur S; Tran VTA; Tran M; Diep YN; Cho H; Lee LP
Biosensors (Basel); 2023 Feb; 13(2):. PubMed ID: 36831997
[TBL] [Abstract][Full Text] [Related]
40. Next generation human skin constructs as advanced tools for drug development.
Abaci HE; Guo Z; Doucet Y; Jacków J; Christiano A
Exp Biol Med (Maywood); 2017 Nov; 242(17):1657-1668. PubMed ID: 28592171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
